Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 87Glioblastoma 85Sarcoma 82Central Nervous System Neoplasms 50Dendritic Cell Sarcoma, Interdigitating 33Lymphoma 31Burkitt Lymphoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, Non-Hodgkin 26Lymphoma, Large-Cell, Immunoblastic 26Lymphoma, Large B-Cell, Diffuse 26Leukemia 26Lymphoma, Follicular 24Lymphoma, Mantle-Cell 23Myelodysplastic Syndromes 22Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell, Marginal Zone 21Leukemia, Myeloid, Chronic-Phase 21Recurrence 20Astrocytoma 20Leukemia, Myeloid, Accelerated Phase 19Hodgkin Disease 19Blast Crisis 18Multiple Myeloma 17Leukemia, Myeloid, Acute 17Liposarcoma 16Glioma 16Rhabdomyosarcoma 15Neoplasms, Plasma Cell 15Brain Neoplasms 14

Interventions

interferon gamma-1b 1Temozolomide 1Radiotherapy 1Radiation 1Oncolytic Virotherapy 1Interferon-gamma 1Immunotherapy 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Diseases × Radiotherapy × Sarcoma × Clear all
NCT00895960 2018-11-08

Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma

M.D. Anderson Cancer Center

Phase 1 Terminated
16 enrolled
CNSSarcoma

Brain Diseases, Central Nervous System Diseases, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡